Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,617 | -2,370 | -2,922 | -5,784 | -5,528 |
| Depreciation Amortization | 4,027 | 2,059 | 8,499 | 6,015 | 4,085 |
| Income taxes - deferred | N/A | N/A | -2,861 | N/A | -96 |
| Accounts receivable | 2,681 | N/A | -2,792 | 918 | -993 |
| Accounts payable and accrued liabilities | -1,382 | -118 | N/A | -442 | 1,798 |
| Other Working Capital | -1,267 | -953 | -1,675 | -990 | 2,623 |
| Other Operating Activity | 1,225 | 3,392 | 4,635 | 574 | -164 |
| Operating Cash Flow | $2,667 | $2,010 | $2,884 | $291 | $1,725 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 597 | -143 | -986 | -891 | -634 |
| Net Acquisitions | N/A | N/A | -52,794 | -52,254 | -52,254 |
| Other Investing Activity | -9 | -9 | -16 | -24 | -24 |
| Investing Cash Flow | $588 | $-152 | $-53,796 | $-53,169 | $-52,912 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 2,300 | N/A | 70,700 | 70,800 | 68,500 |
| Debt Repayment | -8,503 | -4,583 | -20,198 | -19,947 | -17,247 |
| Common Stock Issued | -334 | -421 | 4,557 | 4,521 | 1,380 |
| Other Financing Activity | 0 | 0 | -2,006 | -1,967 | -1,928 |
| Financing Cash Flow | $-6,537 | $-5,004 | $53,053 | $53,407 | $50,705 |
| Exchange Rate Effect | 43 | 3 | 299 | 399 | 373 |
| Beginning Cash Position | 8,173 | 8,173 | 5,733 | 5,733 | 5,733 |
| End Cash Position | 4,934 | 5,030 | 8,173 | 6,661 | 5,624 |
| Net Cash Flow | $-3,239 | $-3,143 | $2,440 | $928 | $-109 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,667 | 2,010 | 2,884 | 291 | 1,725 |
| Capital Expenditure | -423 | -143 | -986 | -891 | -634 |
| Free Cash Flow | 2,244 | 1,867 | 1,898 | -600 | 1,091 |